Effects of Lactiplantibacillus plantarum HY7715 Supplementation on Lower Limb Muscle Strength and Power in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
Hong Dong-Ki DK, Jeon Soomin S, Woo Seonwook S, Shin Sangyeon S et al.
Age-associated reductions in muscle strength and physical function have become an important public health concern among older adults, and gut microbiome-targeted interventions have emerged as a potential strategy to mitigate these declines. We evaluated the effects of Lactiplantibacillus plantarum HY7715 (L. plantarum HY7715) on lower-limb muscle function, serum vitamin B2, and gut microbiome profiles in older adults exhibiting reduced muscle strength. In this 12-week, randomized, double-blind, placebo-controlled trial, 100 adults aged 50-85 years were assigned to receive HY7715 (5.0 × 109 CFU/day) or placebo. Compared with placebo, HY7715 supplementation was associated with greater increases in multiple measures of quadriceps strength, with the left and bilateral mean measures remaining significant after baseline adjustment. Selected hamstring strength and quadriceps muscle power outcomes also showed significant improvements in the unadjusted analyses. Overall, the most consistent findings were observed for quadriceps strength, whereas the hamstring strength and quadriceps muscle power findings were less consistent after baseline adjustment. Serum vitamin B2 concentration increased significantly following HY7715 supplementation, and the between-group difference remained significant after adjustment for baseline dietary riboflavin intake. Microbiome analyses demonstrated increased Chao1 alpha diversity, significant within-group shifts in beta diversity, and increased relative abundances of Lactiplantibacillus and L. plantarum. HY7715 supplementation was associated with greater increases in selected quadriceps strength measures and serum vitamin B2 concentrations in adults with reduced muscle strength.